Brevan Howard Capital Management LP Compass Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 45,877 shares of CMPX stock, worth $223,879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,877Holding current value
$223,879% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
128Shares Held
143MCall Options Held
1.02MPut Options Held
0-
Tang Capital Management LLC San Diego, CA16.8MShares$82 Million2.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA15.2MShares$74.3 Million1.95% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.1MShares$68.8 Million1.59% of portfolio
-
Blackstone Inc New York, NY9.84MShares$48 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA9.55MShares$46.6 Million5.69% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $494M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...